investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Gene and cell ↓2.64   Biotechnology ↓1.1   Immunology ↓0.72 «See more»   Pharmaceutical  ↑6.06   Disease: Metabolic disorders ↑6.06   Respiratory therapies / Pulmanory ↑6.06

Disease: Central nervous system (CNS) stock segment: trending tickers

CYCN Cyclerion Therapeutics, Inc. - Common Stock 2.08% 2.08% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1755237/000119312526219478/0001193125-26-219478-index.htm
10-Q - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock -2.27% -2.27% 0 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1689548/000168954826000069/0001689548-26-000069-index.htm
8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)
+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock -1.1% -1.1% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm
8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock -0.72% -0.72% 0 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1430306/000149315226030408/0001493152-26-030408-index.htm
8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock -3.01% -3.01% 0 + Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1806310/000119312526282855/0001193125-26-282855-index.htm
8-K - Taysha Gene Therapies, Inc. (0001806310) (Filer)
+ My List
VTGN VistaGen Therapeutics, Inc. - Common Stock 0.00% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1411685/000162828026046143/0001628280-26-046143-index.htm
8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
+ My List
RVPH Reviva Pharmaceuticals Holdings, Inc. - Common Stock 6.06% 6.06% 0 + Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1742927/000143774926016762/0001437749-26-016762-index.htm
10-Q - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
+ My List
DRUG Bright Minds Biosciences Inc. - common stock 3.58% 3.58% 0 + Disease: Central nervous system (CNS), Biopharma, Medicine, Disease: Neurology/Alzheimer/Parkinson's

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1827401/000106299326003005/0001062993-26-003005-index.htm
6-K - BRIGHT MINDS BIOSCIENCES INC. (0001827401) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.